Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000919574-14-005268
Filing Date
2014-09-18
Accepted
2014-09-18 16:25:18
Documents
1
Period of Report
2014-09-05

Document Format Files

Seq Description Document Type Size
1 BROADFIN HEALTHCARE MASTER FUND/REPH p6102618.html 3  
1 BROADFIN HEALTHCARE MASTER FUND/REPH p6102618.xml 3 5141
  Complete submission text file 0000919574-14-005268.txt   7665
Mailing Address C/O 20 GENESIS CLOSE ANSBACHER HOUSE, SECOND FLOOR, 1344 GRAND CAYMAN E9 KY1-1108
Business Address C/O 20 GENESIS CLOSE ANSBACHER HOUSE, SECOND FLOOR, 1344 GRAND CAYMAN E9 KY1-1108 212-808-2460
Broadfin Healthcare Master Fund Ltd (Reporting) CIK: 0001511900 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36329 | Film No.: 141110303

Mailing Address 237 PARK AVENUE, 9TH FLOOR NEW YORK NY 10017
Business Address 237 PARK AVENUE, 9TH FLOOR NEW YORK NY 10017 212-808-2463
Broadfin Capital, LLC (Reporting) CIK: 0001511901 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36329 | Film No.: 141110301

Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Issuer) CIK: 0001588972 (see all company filings)

EIN.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BROADFIN CAPITAL, LLC 237 PARK AVENUE, SUITE 900 NEW YORK NY 10017
Business Address
KOTLER KEVIN (Reporting) CIK: 0001601692 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36329 | Film No.: 141110302